Cargando…
Human models as tools in the development of psychotropic drugs
Despite the growing means devoted to research and development (R α D) and refinements in the preclinical stages, the efficiency of central nervous system (CMS) drug development is disappointing. Many drugs reach patient studies with an erroneous therapeutic indication andlor in incorrect doses. Apar...
Autores principales: | Gilles, Christian, Schunck, Thérèse, Erb, Gilles, Namer, Izzie Jacques, Hodé, Yann, Nedelec, Jean-François, Boeijinga, Peter, Luthringer, Remy, Mâcher, Jean-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181700/ https://www.ncbi.nlm.nih.gov/pubmed/22034241 |
Ejemplares similares
-
fMRI in anxiety
por: Schunck, Thérèse, et al.
Publicado: (2003) -
Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment
por: Macher, Jean-Paul, et al.
Publicado: (2004) -
Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers
por: Boeijinga, Peter H.
Publicado: (2002) -
Biomarkers in development of psychotropic drugs
por: Wiedemann, K.
Publicado: (2011) -
Evolution des données de neuro-imagerie chez les patients COVID-19 sévères avec atteinte neurologique initiale
por: LERSY, François, et al.
Publicado: (2022)